Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if hydroxyurea therapy is effective in the
prevention of chronic end organ damage in pediatric patients with sickle cell anemia.